» Articles » PMID: 21887390

The Clinical Features of Spinal Leptomeningeal Dissemination from Malignant Gliomas

Overview
Date 2011 Sep 3
PMID 21887390
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The incidence of leptomeningeal dissemination from malignant glioma is rare, so the clinical features of this are not well documented yet. We attempted to determine the clinical features of leptomeningeal dissemination from malignant gliomas.

Methods: We retrospectively analyzed 11 cases of leptomeningeal dissemination of malignant glioma, who were treated at our institution between 2006 and 2009. We investigated the clinical features of these patients by considering the following factors : tumor locations, the events of ventricular opening during surgery and the cerebrospinal fluid (CSF) profiles, including the cytology.

Results: The group was composed of 9 males and 2 females. The histological diagnosis of their initial intracranial tumors were 4 primary glioblastoma, 3 anaplastic astrocytoma, 1 anaplastic oligoastrocytoma, 2 ganglioglioma and 1 pleomorphic xanthoastrocyotma with anaplastic features. The mean age of the patients at the time of the initial presentation was 42.8±10.3 years. The mean time between surgery and the diagnosis of spinal dissemination was 12.3±7.9 (3-28) months. The mean overall survival after dissemination was 2.7±1.3 months. All our patients revealed a history of surgical opening of the ventricles. Elevated protein in the CSF was reported for eight patients who had their CSF profiles checked.

Conclusion: We propose that in the malignant gliomas, the surgical opening of ventricles can cause the spinal leptomeningeal dissemination and the elevated protein content of CSF may be a candidate marker of leptomeningeal dissemination.

Citing Articles

Primary diffuse leptomeningeal glioblastoma: a case report and literature review.

Mondia M, Hooks R, Maragkos G, Smith V, McCord M, Donahue J J Neurooncol. 2024; 172(1):265-272.

PMID: 39666263 PMC: 11832630. DOI: 10.1007/s11060-024-04908-8.


Clinical Reasoning: A 63-Year-Old Man With Progressive Multicranial Neuropathy and Leptomeningeal Enhancement.

Taga A, Romo C, Rajan S, Lin D, Tobin G, Venkatesan A Neurology. 2024; 103(12):e210100.

PMID: 39586052 PMC: 11590232. DOI: 10.1212/WNL.0000000000210100.


The Patterns of Failure and Prognostic Impact of Tumor Location in Patients Undergoing Reirradiation for Glioblastoma.

Reinders A, Koshy M, Korpics M Cureus. 2024; 16(9):e68820.

PMID: 39371788 PMC: 11456336. DOI: 10.7759/cureus.68820.


Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities.

Park Y, Han K, Kim S, Kwon H, Ahn S, Moon J J Neurooncol. 2023; 162(1):59-68.

PMID: 36841906 PMC: 10050057. DOI: 10.1007/s11060-022-04233-y.


Clinical characteristics and prognosis of Glioblastoma patients with infratentorial recurrence.

Kawauchi D, Ohno M, Honda-Kitahara M, Miyakita Y, Takahashi M, Yanagisawa S BMC Neurol. 2023; 23(1):9.

PMID: 36609238 PMC: 9824996. DOI: 10.1186/s12883-022-03047-9.


References
1.
Grabb P, Albright A, Pang D . Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery. 1992; 30(1):64-71. DOI: 10.1227/00006123-199201000-00012. View

2.
Vredenburgh J, Desjardins A, Herndon 2nd J, Marcello J, Reardon D, Quinn J . Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007; 25(30):4722-9. DOI: 10.1200/JCO.2007.12.2440. View

3.
Erlich S, Davis R . Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer. 1978; 42(6):2854-64. DOI: 10.1002/1097-0142(197812)42:6<2854::aid-cncr2820420647>3.0.co;2-4. View

4.
Lee Y, Glass J, Geoffray A, Wallace S . Cranial computed tomographic abnormalities in leptomeningeal metastasis. AJR Am J Roentgenol. 1984; 143(5):1035-9. DOI: 10.2214/ajr.143.5.1035. View

5.
Yung W, Horten B, Shapiro W . Meningeal gliomatosis: a review of 12 cases. Ann Neurol. 1980; 8(6):605-8. DOI: 10.1002/ana.410080610. View